Introduction
Human papillomavirus (HPV) is associated with various cancer types in both men and women. Among women, in 2012, HPV was associated with 74% of cancer cases, 70% of which were cervical cancer. 1 In men, HPV DNA is detected in around 50% of all penile cancers.
2 HPV 16, HPV 18, and HPV 6/11 are considered the most common causes of HPV-related penile tumors. 3 HPV vaccination is an effective method to diminish the risk of HPV transmission in both genders. 5 In 2008, the US Food and Drug Administration licensed the first vaccine that could prevent 70% of cervical cancers and diseases associated with HPV 16 and 
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Tran et al HPV 18 . A systematic review of cost-effectiveness analyses endorsed the need for HPV vaccine combined with screening tests to reduce costs, save time, and prolong the effects of the vaccine. 4 However, in developing countries, the uptake of HPV immunization among the target population remains low. [12] [13] [14] One study revealed that HPV vaccine uptake among Vietnamese young people (5.7%) was significantly lower than that of their US counterparts (42%). 15 Reasons for this phenomenon include high cost, 6, 7 lack of knowledge about the HPV vaccine, 8 negative attitudes toward the HPV vaccine, 9 and fear of side effects. 10, 11 Moreover, empirical evidence indicated that the integration of HPV vaccination into preventive strategies may face several barriers related to knowledge, attitude, practice, and willingness to pay (WTP) for this vaccine. 16, 17 The Ministry of Health in Vietnam has exempted fees for vaccine services to children aged under 6 years, but people need the provide co-payment for other vaccines such as rubella, Haemophilus influenzae, hepatitis B, and HPV vaccines. 18 During 2006-2010, the Vietnam National Institute of Hygiene and Epidemiology collaborated with the Program for Appropriate Technology in Health to implement school-based and health center-based HPV vaccine demonstration projects to 11-year-old females. 19 The project ended successfully and gained a high level of public acceptability. 20 Since 2016, the country has no longer qualified for support from the Global Alliance for Vaccines and Immunization. 21 People have to pay the full price for each dose of HPV vaccine, which costs around US$100, and this could be a financial burden.
Our study aimed to investigate knowledge-attitudepractice (KAP), WTP, and factors associated with WTP for the HPV vaccine among those using the services of an urban vaccination clinic in Hanoi, Vietnam. Our findings could be useful for the Ministry of Health in Vietnam, which is considering incorporating HPV vaccination into the national Expanded Program on Immunization.
Materials and methods study setting and sampling method
We conducted a cross-sectional study at the Institute of Preventive Medicine and Public Health vaccination clinic, Hanoi, Vietnam, from March to April 2016. We chose this clinic based on several factors. First, it is located in the center of Hanoi; thus, the characteristics of users were likely to reflect the dynamic socioeconomic characteristics of urban people. Second, this clinic has sufficient service users to meet the study sample size. Subjects were included in the study if they met the eligibility criteria: 1) were vaccine service users, 2) were at least 18 years old, 3) agreed to enroll in the study and signed a written informed consent, and 4) were cognitively healthy.
Under the scope of this study, a convenience sampling approach was applied to recruit both male and female participants. This method allowed us to reach all available subjects in the clinic where the sampling frame was not available. After eligible subjects provided written informed consent to confirm they were invited to a private room for face-to-face interviews to ensure confidentiality. A total of 429 subjects participated in this study.
Measurements and instruments
Face-to-face interviews were conducted using a structured questionnaire to collect self-reported data. We were aware that our study might be affected by recall bias and social desirability bias. The former bias could occur when service users incompletely remember events in the past, while the latter bias may occur when respondents want to please the medical staff, resulting in overestimating or underestimating the outcomes of interest. We applied several solutions to address these biases. First, we recruited interviewers who were not affiliated with the vaccination clinic and received sufficient training. Second, the interviewers explained clearly the purpose of the study to the subjects before interviewing and allowed sufficient time for subjects to recall accurate memories. Third, the questionnaire was designed in an understandable way. Finally, because some couples brought their children to the clinic together, we ensured that the mother and father were not interviewed twice by checking when we invited them to the study.
sociodemographic characteristics
We collected data about age, gender, educational attainment, marital status, current occupation, and monthly household income.
Knowledge, attitude, and practice about hPV vaccination
Since a validated questionnaire is not available in Vietnam, we developed a series of questions based on previous studies in settings with a similar sociocultural context to Vietnam to examine KAP about HPV vaccination, and conducted a pilot study to test the validity and reliability of the questionnaire. Knowledge about HPV vaccination was measured by asking the respondents about the target group for HPV vaccination, benefits of HPV vaccination, and the best age 
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KAP and WTP for hPV vaccine for vaccination. In terms of attitude, we asked people about their belief in the safety and efficacy of the vaccine and their desire for vaccine uptake by asking the following questions: "Do you believe that HPV vaccine is safe?", "Do you believe that HPV vaccine is efficient?", and "Do you want to get the HPV vaccine?" In terms of practice, we asked whether subjects have received HPV vaccinations before and, if not, the reasons why they had not received the vaccine.
Willingness to pay for hPV vaccination
We used a contingent valuation method to examine the WTP for HPV vaccination services, with a starting price of 1.8 million VND (~US$81, 2016 exchange rate) (Figure 1 ). First, subjects were asked "Are you willing to pay 1.8 million VND per dose for HPV vaccine?" The price doubled or dropped by a half depending on the respondent's answer (Yes or No). The question was repeated until the last price reached four times higher or eight times lower than the initial price. Finally, subjects were asked about the maximum price that they were willing to pay for a dose of HPV vaccine.
statistical analysis
Data were analyzed using STATA software (version 12.0). For missing data, the highest proportion of missing data was 6.1%, for the desire to be vaccinated. The chi-squared test was used to assess differences in sociodemographic variables (age, education, marital status, and occupation), sources of seeking HPV information, KAP about the HPV vaccine, sexually transmitted infections (STIs), and use of reproductive health services between the genders. Logistic and interval regressions were used to identify factors associated with WTP and the amount that people were willing to pay.
A forward stepwise strategy with a threshold of p,0.2 was applied to shorten the regression model. A p-value ,0.05 was considered statistically significant.
ethics approval and informed consent
The study was approved by Ethical Committee of Hanoi Medical University. Subjects were told about the purpose of this study and asked to give their written informed consent if they agreed to participate in the study. Subjects could withdraw from the study at any time without any interruption of their services at the clinic. They were assured that their information would remain confidential.
Results
The majority of the sample had received at least a highschool level of education (63.2%). Half of the respondents were single, divorced, or widowed (50.6%). The mean±SD age was 26.8±6.2 years and the average monthly household income was 15.9±32.2 million VND (Table 1) . Table 2 presents the different ways of seeking HPVrelated information. Social networks and the internet (56.8%), and doctors, nurses, and other health professionals (41.9%) were common channels used to obtain information on the HPV vaccine. Of note, the internet, news, and television were the most popular channels used to seek HPV vaccine information, accounting for 66.8%. The rate of seeking HPV vaccine information in females was significantly higher than that in males (p,0.01). Table 3 summarizes KAP about HPV vaccination. The percentages of subjects correctly answering questions regarding the best age for HPV vaccination, the benefits of HPV vaccination, and the target subject for HPV vaccination were 67.9%, 94.6%, and 12.3%, respectively. The subjects' history of STIs and use of reproductive health service are shown in Table 4 . Most subjects had never been infected with STIs (90.1%) or genital herpes (94.4%). Nearly 30% of subjects had ever had a reproductive health examination, and 46% of these respondents were examined every 6 months.
The WTP for the HPV vaccine is presented in Table 5 . Most respondents were willing to pay for the HPV vaccine (86.6%), with an average amount of 1.119 million VND. Table 6 shows that those aged 20-29 years were more likely to be willing to pay for HPV vaccine than those aged ,20 years (OR = 6.99, 95% CI 1.62 to 30.21). People who earned more than 22 million VND/month (very rich) were willing to pay for HPV vaccine at a higher price than those who earned ,7 million/month (very poor) (coefficient = 474.91, 95% CI 82.19 to 867.63). Service users who had attained education above high school were willing to pay for the vaccine at a lower price than those had less than secondary education (coefficient = -572.98, 95% CI -936.33 to -209.64). Those who had children above 6 years old were willing to pay a higher price for the HPV vaccine (coefficient = 1,294.77, 95% CI 161.91 to 2,427.63). People who were informed about HPV by doctors, nurses, or other health professionals were willing to pay a lower price for the HPV vaccine (coefficient = -443.34, 95% CI -719.17 to -167.51).
Discussion
This study provides a step toward a better understanding of barriers to HPV vaccination uptake in Hanoi, Vietnam. Our findings highlighted a low rate of service users having sufficient KAP towards HPV vaccination, but a high proportion of respondents were willing to pay for HPV vaccine, at an average cost of 1.119 million VND (US$49.3) per dose. Moreover, some factors associated with the WTP for HPV vaccine were found, suggesting potential implications for further scaling-up of HPV vaccination in Vietnam.
In this study, we found that one-third of service users were vaccinated against HPV infection. This vaccine uptake rate (31.8%) was higher than a previous study in Vietnam (2.3%) 24 but lower than a study in China (47.2%), and in European countries such as Germany (53%) 25 and the Netherlands (49.9%). 26 Of note, we observed that very few people answered correctly the question about the target group for HPV vaccination. This may be explained by the fact that HPV vaccination programs have largely focused on women and young adolescent girls as there is a close link to cervical cancer. 22 However, this may lead to erroneous perceptions of the target group for HPV vaccination in that this vaccine is for both males and females. Moreover, men may perceive that the HPV vaccine is not necessary. 23 This raises the need for knowledge enhancement efforts which emphasize the benefits of HPV vaccination in both men and women.
The estimated amount that people were willing to pay for the HPV vaccine in this sample was approximately twothirds of the actual price in the vaccination clinic (1.8 million VND per dose). This amount was lower than that in the USA, 27 where mothers would pay an average of US$663 for the three-dose course. In other studies in Thailand and Mexico, people were willing to pay US$200 for three doses 
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Tran et al and US$45-240 for three doses, 28 respectively. The reason for this may be because this amount could still be a financial burden as the three-dose HPV vaccine course represented about 21% of general monthly household income and nearly 7% of Vietnamese annual income. 29 A previous study conducted in Binh Dinh, Vietnam, also indicated the high cost as a major barrier to HPV vaccination. 24 Our results highlight the need for financial support and the inclusion of the HPV vaccine in the National Immunization Program.
Our findings suggest that individuals between the ages of 20 and 29 years were most likely to pay for the vaccine. Sexual health topics are often avoided in discussions at school or in the family. 30 Some people even believe that sexuality and relationships are not appropriate for adolescents and young adults because education must be prioritized. 31 However, this may lead to a lack of essential knowledge about sexual health. In the context of Vietnam, those between 20 and 29 years old are more likely than others to be in a romantic relationship, become sexually active, and care about sexual health. Thus, the expansion of school-based sexual health education could be a vital aspect of any public health initiative to increase the knowledge regarding prevention of STIs. Although receiving HPV vaccination before becoming sexually active can reduce the risk of cervical cancer, the rate of vaccination uptake remains low owing to high prices, especially in developing countries. 32 Very rich subjects were more willing to pay the higher price than their very poor counterparts. While this result is in line with a previous study in Vinh Long, Vietnam, 18 a study in Binh Dinh, Vietnam, found no association between household economics and HPV vaccination. 24 Nevertheless, our study affirms the existence of financial barriers to HPV vaccination.
This study suggests that those had higher than a highschool level of education tended to pay for the vaccine at a lower price than those who had lower than the secondaryschool level. This finding is in line with the previous literature. 33, 34 It is widely acknowledged that well-educated people tend to chart their own course on the issue of vaccines. 35, 36 In this respect, these people may enrich their knowledge themselves by cross-referencing reputable information on the internet, where they gather a lot of misinformation about vaccination. While a large body of literature shows that physicians play an important role in increasing HPV vaccine uptake, 37, 38 we found that subjects who had heard about the HPV vaccine from doctors, nurses, health professionals, and community health workers were less likely than others to be willing to pay for the vaccine. Several studies have pointed out that the high cost of the HPV vaccine is a major barrier to recommending the HPV vaccine. 39, 40 More affordable alternatives, such as using condoms and having a single sexual partner, may be prioritized. This could orientate people towards alternatives other than HPV vaccination. Future studies should draw attention to physicians' perceived barriers to recommending HPV vaccine. This may enrich the understanding about barriers to expanding HPV vaccine from the physician's perspective.
Several recommendations can to be drawn from the study. First, sexual health education should be extensively implemented in dynamic forms such as media, workshops, and school curriculums to promote KAP about HPV vaccination among the target populations. Second, the government should mobilize financial resources to reduce the cost of the HPV vaccine. Finally, there needs to be a strong collaboration among stakeholders to introduce the HPV vaccine into the National Immunization Program. Future research could focus on physicians' perceived barriers to recommending the HPV vaccine in the context of Vietnam, and the characteristics of those people who know little about HPV and are not willing to pay for the HPV vaccine.
This study reflects viewpoints from both males and females, which allows us to capture a more comprehensive picture of KAP and WTP for the HPV vaccine in the general population. However, we acknowledge several limitations. First, owing to the nature of the design, we cannot establish causal links between WTP for the HPV vaccine and its associated factors. Second, we recruited our sample by using the convenience sampling technique, which limits the capacity to generalize our results to other settings. Moreover, this study was carried in the vaccination clinic, where people may have better KAP and a high WTP for the HPV vaccine than those in the community. Finally, although some preventive procedures were followed, recall bias and social desirability bias may have occurred, which could affect the main findings of this study.
Conclusion
Most subjects in this study had misconceptions about the target group for HPV vaccination, and the vaccination rate was low, especially in males. The majority was willing to pay for the vaccine and the average amount they were willing to pay was 1.119 million VND per dose. Age, monthly household income, having children above 6 years old, and sources of hearing about HPV were factors associated with WTP and the amount that people were willing to pay for the HPV vaccine. Enhancing sexual health education among adolescents, reducing the costs of the HPV vaccine, and
